Overview of Stage III NSCLC

Download this slideset for a multidisciplinary expert–curated overview of stage III NSCLC, including insights on staging and standard-of-care chemoradiation strategies as well as an update on contemporary radiation techniques.
Gerard A. Silvestri, MD, MS
Program Director
Kristin Higgins, MD
Mark A. Socinski, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.20 MB
Released: October 21, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Related Content

Webcast of a CCO symposium at CHEST 2019 featuring expert perspectives on optimal integration of immunotherapy into stage III NSCLC care using a multidisciplinary approach

Gerard A. Silvestri, MD, MS
Program Director
Kristin Higgins, MD Mark A. Socinski, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit US Physicians: maximum of 1.0 Medical Knowledge MOC point(s) Released: November 20, 2019 Expired: No longer available for credit

In this slideset, a multidisciplinary expert panel reviews the latest clinical data supporting the optimal use of checkpoint inhibitor therapy for stage III NSCLC.

Gerard A. Silvestri, MD, MS
Program Director
Kristin Higgins, MD Mark A. Socinski, MD
Released: October 21, 2019

In this slideset, a multidisciplinary expert panel provides insights on optimal use of checkpoint inhibition in the treatment of a series of patient cases with stage III NSCLC.

Gerard A. Silvestri, MD, MS
Program Director
Kristin Higgins, MD Mark A. Socinski, MD
Released: October 21, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue